Oric Pharmaceuticals Inc. (ORIC) Social Stream



Oric Pharmaceuticals Inc. (ORIC): $6.03

0.03 (+0.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ORIC to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

ORIC PHARMACEUTICALS INC (ORIC) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ORIC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 6 $52 $31 $39.333 $5.63 598.63%
2022-01-26 6 $52 $31 $38.166 $5.63 577.9%
2022-03-22 7 $45 $7 $26 $5.63 361.81%
2022-04-04 6 $33 $10 $19 $5.63 237.48%
2022-05-11 6 $17 $10 $13.666 $5.63 142.74%
2022-08-12 6 $17 $10 $14 $5.63 148.67%
2022-11-08 6 $15 $10 $12.5 $5.63 122.02%
2022-12-09 6 $16 $10 $13.666 $5.63 142.74%

The Trend in the Analyst Price Target


Over the past 25 months, ORIC's average price target has gone down $31.5.

ORIC reports an average of 310.16% for its upside potential over the past 37 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-22 7 33 7 18.000 4.76 278.15%
2022-03-22 7 45 7 26.000 4.76 446.22%
2022-03-22 6 45 7 26.000 4.76 446.22%
2022-04-20 6 17 10 13.666 3.89 251.31%
2022-05-11 6 17 10 13.666 2.73 400.59%

ORIC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 3 0 3 0 0 6

The Trend in the Broker Recommendations


ORIC's average broker recommendation rating worsened by 0.67 over the prior 48 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ORIC PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 958.66% of all US stocks.
  • ORIC PHARMACEUTICALS INC's average analyst price target is greater than 289.94% of all US stocks.
  • In terms of how ORIC PHARMACEUTICALS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -668.57% of that group.
  • In the context of stocks in the small market cap category, ORIC PHARMACEUTICALS INC's number of analysts covering the stock is higher than 860.66% of them.

Stocks similar to ORIC PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PLRX, CALT, and RNA.

What is the outlook for ORIC? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6028 seconds.